What Dominion Diagnostics does

Dominion Diagnostics is a privately held, CLIA-certified and CAP-accredited clinical toxicology reference laboratory founded in 1997 by toxicologists and PhDs with specialization in addiction medicine. The company's core offering centers on definitive urine drug testing using LC-MS/MS (Ultra Performance Liquid Chromatography/Tandem Mass Spectrometry) with industry-low detection limits, complemented by oral fluid testing, urine STI testing, and blood testing. Results are delivered through the proprietary Dominion Connect online portal — provided at no cost — along with two clinically-validated, proprietary reporting modules: CARD (Comprehensive Analysis of Reported Drugs) for substance use disorder treatment and SAMM (Scientifically Accurate Medication Monitoring) for pain management. A peer-reviewed PLOS ONE study of over 10,000 patients supports the CARD reporting system. The company also offers an Automated Randomization Tool, Treatment Outcome Reports, Telehealth Solutions via HIPAA-compliant Zoom, NAADAC-accredited clinical education programs, and real-time clinical pharmacist consultation with a 99.8% answer rate.

The business operates a sales-led go-to-market motion combining regional field sales executives with an inside sales department, addressing four primary verticals: substance use disorder treatment providers, pain management clinics, behavioral health programs, and MAT/Opioid Treatment Programs, with a secondary push into health plans and managed care. Revenue is generated transactionally through laboratory testing fees billed directly to insurance carriers (Medicare, Medicaid, and most commercial plans), patient responsibility collections, sliding-scale self-pay arrangements, and account billing for treatment centers. The company operates eight physical Patient Service Centers across New England, Tennessee, and Utah, supported by a national exclusive courier network that delivers over 60% of specimens to the lab by midnight for three-shift processing. The company differentiates through 24-hour preliminary and 72-hour LCMS definitive turnaround times, custom EMR integrations with over 100 EHR systems via Change Healthcare, and a voluntary compliance program established in 2004 — one of the longest-running in the industry.

Dominion Diagnostics is led by CEO Robert M. Garvey, Jr. (joined 2011, previously SVP at LabCorp's Northeast division generating over $800M in annual revenue, plus senior roles at Quest Diagnostics and GE Healthcare), supported by a ten-person executive team recruited from LabCorp, Quest, PerkinElmer, Calloway Labs, and other incumbent reference labs. The company is founder- and management-backed with no disclosed external private equity or venture capital and no M&A activity in the source data. Headcount is approximately 318 employees operating across 30+ states, with three consecutive years of Great Place to Work certification (90% affirmation in 2026) and eleven consecutive years of BlueCross BlueShield of Rhode Island Worksite Health Awards.

Name

Dominion Diagnostics

Legal name

Dominion Diagnostics LLC

Website

https://domdiag.com

Company type

Private

Founded year

1997

Operating status

Operating

Short description

Dominion Diagnostics is a privately held, CLIA-certified clinical toxicology reference laboratory providing LC-MS/MS urine drug testing, proprietary reporting systems, and telehealth-friendly monitoring services to substance use disorder, pain management, behavioral health, and MAT providers across the United States.

Ownership category

akta.pro rank

Product category

Clinical Toxicology Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Ambulatory Health Care Services (621)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Urinalysis & Routine Screening Diagnostics (HLAHAAAG)

akta.pro secondary industries

Bioanalytical Testing (PK/ADA/NAb) (HLAGADAA), At-Home Lab Testing & Diagnostics-Integrated Virtual Care (HLALAAAE)

Keywords

• Clinical toxicology laboratory
• Urine drug testing
• Medication monitoring services
• Substance use disorder testing
• Pain management diagnostics

Headquarters

HQ city

North Kingstown

HQ country

United States

HQ region

North America

Offices10 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Laboratory Testing Services: Fee-for-service laboratory testing billed to insurance carriers, Medicare, Medicaid, or self-pay patients. Services include urine drug testing, oral fluid testing, STI testing, and blood testing.
2. Insurance Billing: Dominion Diagnostics bills directly to patient insurance as a Medicare and Medicaid provider and in-network provider with most commercial insurance plans. Collects co-pays, deductibles, and fees deemed patient responsibility by insurance.
3. Direct Patient Billing: Direct billing to uninsured patients at Usual and Customary Charge (UCC) rates, with payment schedule options based on financial need. Sliding fee scale available.
4. Account/Provider Billing: In certain situations (e.g., treatment centers serving self-pay clients), Dominion sets up account billing for direct customer invoicing through online provider bill pay portal.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels7 records

Core offering

Dominion Diagnostics is a national clinical toxicology laboratory that delivers definitive urine drug testing using UPLC-MS/MS technology, supported by oral fluid, STI, and blood testing, with results delivered through the Dominion Connect portal and proprietary CARD and SAMM reporting systems. The company serves healthcare providers in substance use disorder treatment, pain management, and behavioral health with medication monitoring, compliance verification, and clinical decision support across a national footprint of field sales, patient service centers, and courier logistics.

Product overview

Dominion Diagnostics provides a unified laboratory testing platform focused on clinical drug monitoring for healthcare providers. The core offering centers on definitive urine drug testing using LC-MS/MS technology, complemented by oral fluid, STI, and blood testing services. Results are delivered through the Dominion Connect proprietary portal, which integrates with major EHR systems via Change Healthcare. Two key reporting modules serve distinct specialties: CARD (Comprehensive Analysis of Reported Drugs) for substance use disorder treatment and SAMM (Scientifically Accurate Medication Monitoring) for pain management. Supporting modules include the Automated Randomization Tool, Treatment Outcome Reports, Telehealth Solutions, Clinical Education/Training, and Clinical Pharmacist Consultation Services. The platform is offered at no cost to clients, with testing services billed to insurance or patients.

Differentiator

Problem solved

Functional benefit

Products and services

• Urine Drug Testing (UDT)
• Oral Fluid Testing (OFT)
• Urine STI Testing
• Blood Testing
• Dominion Connect Portal
• Custom EMR Integrations
• CARD Reporting (Comprehensive Analysis of Reported Drugs)
• SAMM Reporting (Scientifically Accurate Medication Monitoring)
• Treatment Outcome Reports
• Telehealth Solutions
• Clinical Education and Training
• Clinical Pharmacist Services

Quantifiable outcome

• Peer-reviewed study demonstrates improved patient outcomes with CARD reporting utilization in treatment settings
• +3 more outcomes

Named customers9 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature6 records

Partnerships

Six partnerships are on record, tiered minor, core and supporting.

• Vermont Foundation of RecoveryminorStrategic or Co-development Partner · 10 December 2018Established new scholarship advancing addiction recovery in Vermont state to support access to recovery residences.
• Institute for the Advancement of Behavioral HealthcarecoreStrategic or Co-development Partner · 9 January 2018Extended partnership over two years to support education for addiction treatment professionals facing substance abuse and addiction crisis. Long-standing partnership for addiction treatment education.
• Change HealthcarecoreTechnology or IntegrationPartnership to enable custom EMR/EHR integrations. Dominion Diagnostics interfaces with over 100 different EHR systems through Change Healthcare for seamless ordering and results delivery directly into provider workflows.
• ZoomsupportingTechnology or IntegrationHIPAA-compliant video platform used for telehealth program observation process to maintain privacy and confidentiality during remote patient collections.
• Northeastern UniversitysupportingStrategic or Co-development PartnerUniversity partnership for research, training, and internships. Features Dominion Diagnostics Director of R&D Lawrence Andrade in alumni news.
• BlueCross BlueShield of Rhode IslandcoreChannel Partner/ Reseller/ DistributorHealth plan partnership for Worksite Health Awards program recognizing employer wellness initiatives. BCBSRI sponsors annual awards program.

Scale indicators7 records

Recent moves6 records

Expansion highlights12 records

Direct peers

• Millennium Health: Leading specialty toxicology laboratory providing urine drug testing and oral fluid testing with LC-MS/MS, serving substance use disorder treatment, pain management, and behavioral health providers across the U.S. Direct competitor to Dominion with overlapping proprietary reporting and similar clinical customer base.
• Aegis Sciences Corporation: Specialty clinical laboratory focused on forensic toxicology, pain management drug monitoring, and substance use disorder testing using LC-MS/MS. Closely comparable to Dominion in target customers (SUD clinics, pain practices), technology stack, and interpretive reporting.
• Cordant Health Solutions: Specialty toxicology and medication-monitoring laboratory serving addiction treatment, pain management, and behavioral health providers with definitive drug testing services. Directly comparable product portfolio and customer base to Dominion, including leadership pedigree overlap.
• Precision Toxicology: Specialty toxicology laboratory providing LC-MS/MS-based urine drug testing and oral fluid testing to addiction treatment and pain management providers. Closely aligned with Dominion in technology, customer segments, and compliance posture for SUD/pain monitoring.

Broad incumbents

• Quest Diagnostics: One of the two largest U.S. clinical reference laboratories offering an extensive menu including toxicology and pain management drug monitoring, alongside routine and esoteric diagnostics. Competes with Dominion in UDT but with broader test menu, larger payer contracts, and national infrastructure.
• Laboratory Corporation of America (LabCorp): One of the largest U.S. clinical reference laboratories providing routine and specialty diagnostics, including urine drug testing for pain management and addiction medicine. Overlaps with Dominion on UDT but serves a far broader menu of testing and customer segments at national scale.
• ARUP Laboratories: Large nonprofit academic reference laboratory offering a broad esoteric menu including toxicology, pain management drug monitoring, and clinical pharmacology testing. Comparable in advanced testing capability but with a more academic medical center customer base and broader menu than Dominion.
• Sonic Healthcare USA: Global clinical laboratory network with U.S. operations offering routine and specialty diagnostics, including drug monitoring. A scaled incumbent that competes with Dominion on toxicology volume through its regional lab footprint.

Emerging players

• Calloway Labs: Smaller specialty toxicology and clinical laboratory with nationwide field operations that previously employed Dominion's SVP of Customer Operations. Comparable to Dominion in specialty drug monitoring focus but with smaller scale and limited public visibility.
• Pathway Diagnostics: Specialty laboratory with focus on toxicology and compliance testing serving addiction treatment and pain management providers. Comparable to Dominion in clinical positioning and customer overlap, though smaller and less differentiated on reporting.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xtwitter.com/dominiondiagnostics
• Facebookfacebook.com/DominionDiagnostics
• LinkedInlinkedin.com/company/dominon-diagnostics

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dominion Diagnostics